Status:
COMPLETED
Remote Delivery of Weight Management for Adults With IDD
Lead Sponsor:
University of Kansas Medical Center
Collaborating Sponsors:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions:
Obesity
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to compare different weight loss programs in people with IDD to see which program works better.
Eligibility Criteria
Inclusion
- Diagnosis of mild to moderate IDD as determined by a Community Service Provider operating in Kansas under the auspices of a Community Developmental Disability Organization (CDDO). Participants will be judged competent to provide informed consent by their CDDO, or will have a guardian with power of attorney.
- Ability to provide assent, regardless of guardian consent.
- BMI of 25 to 45 kg/m2
- Sufficient functional ability to understand directions, communicate preferences (e.g. foods), wants (e.g. more to eat/drink), and needs (e.g. assistance with food preparation) through spoken language
- Living at home with a parent/guardian, or in a supported living environment with a caregiver who assists with food shopping, meal planning, and meal preparation and agrees to serve as a study partner
- No plans to relocate outside the study area over the next 24 months
- Internet access in the home
Exclusion
- Unable to participate in moderate-to-vigorous physical activity (MVPA)
- Insulin dependent diabetes
- Participation in a weight management program involving diet and physical activity in the past 6 months
- Serious food allergies, consuming special diets (vegetarian, Atkins etc.), aversion to common foods (e.g., unwilling to consume dairy products, vegetables), diagnosis of Prader-Willi Syndrome
- Pregnancy during the previous 6 months, currently lactating or planned pregnancy in the following 24 months.
- Serious medical risk, e.g., cancer, recent heart attack, stroke, angioplasty
- Unwilling to be randomized.
Key Trial Info
Start Date :
February 21 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 14 2022
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT03291509
Start Date
February 21 2018
End Date
August 14 2022
Last Update
March 7 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Kansas Medical Center
Kansas City, Kansas, United States, 66160